Ziextenzo (Pegfilgrastim)

pegfilgrastim 6 mg/0.6 mL injection, 0.6 mL syringe · INJECTION · PBS code 9514R

STREAMLINED

What it costs

AU$77.52 PBS-determined price per 1 units

Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.

• First listed on the PBS: 2020-03-01.
• Repeats: 11.
• PBS program: HB.

Eligibility criteria for subsidised access

The following is the government's own wording from the PBS Schedule, shown unchanged.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Chemotherapy-induced neutropenia

Patient must be receiving chemotherapy with the intention of achieving a cure or a substantial remission; AND

Patient must be at greater than 20% risk of developing febrile neutropenia; or

Patient must be at substantial risk (greater than 20%) of prolonged severe neutropenia for more than or equal to seven days.

Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1

Chemotherapy-induced neutropenia

Patient must be receiving chemotherapy with the intention of achieving a cure or a substantial remission; AND

Patient must have had a prior episode of febrile neutropenia; or

Patient must have had a prior episode of prolonged severe neutropenia for more than or equal to seven days.

Sponsor: Sandoz Pty Ltd ABN 60 075 449 553

Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.

Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.